Skip to main content
  • Meeting abstract
  • Open access
  • Published:

EHMTI-0202. Study protocol of BoTN: a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgia

Background

Trigeminal neuralgia (TN) is a chronic disorder characterized by paroxysmal facial pain. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects.

Subcutaneous injections of botuinum toxin type A (BT-A) are a promising treatment option for patients with insatisfactory response to drug therapy or neurosurgical intervention.

This is the study protocoll of a prospective, placebo-controlled, double blind clinical trial investigating the add-on therapy of subcutaneous of BT-A injections to standard treatment.

Methods and design

BoTN is a prospective, randomized, double-blind, placebo-controlled trial with a randomized withdrawal design. Eligible patients with classic TN who are otherwise refractory to medical and neurosurgical treatment will receive subcutaneous injections of BT-A into injection sites of the affected trigeminal branch.

In the first phase phase all patients will receive verum in a single blinded intervention and twelve weeks later therapy responders will be 1:1 allocated to the verum or placebo (saline) arm. This time the intervention is double blind and injections will be done at the same sites.

This trial will be conducted in a tertiary outpatient clinic specialized in the treatment of headache and facial pain.

Discussion

BoTN is designed to assess the efficacy and safety of local BT-A injections in additon to standard prophylactic treatment.

No conflict of interest.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burmeister, J., Holle, D., Bock, E. et al. EHMTI-0202. Study protocol of BoTN: a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgia. J Headache Pain 15 (Suppl 1), C9 (2014). https://doi.org/10.1186/1129-2377-15-S1-C9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1129-2377-15-S1-C9

Keywords